Unknown

Dataset Information

0

Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease.


ABSTRACT: A series of homoisoflavonoid derivatives was designed, synthesized and evaluated as potential multi-functional anti-Alzheimer's agents for their inhibitory activity on cholinesterase and monoamine oxidase. Among them, compound 16 showed moderate acetylcholinesterase (AChE) inhibitory activity (eeAChE IC50 = 0.89 ± 0.02 ?M; hAChE IC50 = 0.657 ± 0.002 ?M) and significant monoamine oxidase B (MAO-B) inhibitory activity (hMAO-B IC50 = 0.0372 ± 0.0002 ?M). Kinetic analysis of AChE, MAO-B inhibition and molecular modeling studies revealed that compound 16 is a dual binding site inhibitor of AChE and noncompetitive inhibitor of MAO-B. Furthermore, 16 could penetrate through the blood-brain barrier (BBB) in vitro. Most importantly, oral administration of 16 demonstrated no marked signs of acute toxicity and it could significantly reverse scopolamine-induced memory impairment in mice. These results suggested that compound 16 is a promising multifunctional drug candidate with potential effect for the treatment of Alzheimer's disease.

SUBMITTER: Liu QH 

PROVIDER: S-EPMC6071942 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease.

Liu Qiao-Hong QH   Wu Jia-Jia JJ   Li Fan F   Cai Pei P   Yang Xue-Lian XL   Kong Ling-Yi LY   Wang Xiao-Bing XB  

MedChemComm 20170524 7


A series of homoisoflavonoid derivatives was designed, synthesized and evaluated as potential multi-functional anti-Alzheimer's agents for their inhibitory activity on cholinesterase and monoamine oxidase. Among them, compound <b>16</b> showed moderate acetylcholinesterase (AChE) inhibitory activity (eeAChE IC<sub>50</sub> = 0.89 ± 0.02 μM; hAChE IC<sub>50</sub> = 0.657 ± 0.002 μM) and significant monoamine oxidase B (MAO-B) inhibitory activity (hMAO-B IC<sub>50</sub> = 0.0372 ± 0.0002 μM). Kine  ...[more]

Similar Datasets

| S-EPMC9366597 | biostudies-literature
| S-EPMC6989591 | biostudies-literature
| S-EPMC7469261 | biostudies-literature
| S-EPMC6071962 | biostudies-literature
| S-EPMC9967051 | biostudies-literature
| S-EPMC4207550 | biostudies-literature
| S-EPMC10938434 | biostudies-literature
| S-EPMC6009888 | biostudies-literature
| S-EPMC7027018 | biostudies-literature
| S-EPMC6072412 | biostudies-literature